Disappointing Results for Tecovirimat Mpox Trial in the DRC Medical Countermeasures August 15, 2024 …
Thylacine Biotherapeutics Earns Top Honor in Medical Threat Reduction Challenge Medical Countermeasures July 9, 2024 …
RedHill Announces New Opaganib Chinese Patent Against Ebola Virus Valid Through 2035 Medical Countermeasures May 6, 2024 …
Australians: If You Have the Flu, Should You Ask for Antivirals? Infectious Diseases August 28, 2023 …
DoD Awards ENA Respiratory $4.38M for Broad-Spectrum Antiviral Development Industry News January 10, 2023 …
Texas Biomed Tapped for National ‘Dream Team’ Developing Antivirals Against Biothreats Policy + Initiatives July 16, 2022 …
Antivirals, Some Antibodies, Work Well Against BA.2 Omicron Variant of COVID-19 Virus Medical Countermeasures March 10, 2022 …
Birmingham Biotech and University of Birmingham Partner on Covid-19 Anti-viral Nasal Spray Industry News November 9, 2021 …
New Antiviral Compound Blocks SARS-CoV-2 From Entering Cells Medical Countermeasures October 13, 2021 …
Breakthrough Results for Dengue Antiviral: Janssen Compound Shows Promise Against All Serotypes Industry News October 6, 2021 …
Navrogen Enters CRADA with USAMRIID to Test Small Molecule NK Cell Activators Against SARS-COV-2 Infection Industry News September 13, 2021 …
NIAID to Create New Antiviral Drug Discovery Centers for Pathogens of Pandemic Concern Contracts + Grants July 13, 2021 …
University of Bristol Scientists Form Halo Therapeutics to Develop ‘Pan-Corona’ Antivirals Industry News April 15, 2021 …
SARS-CoV-2 Stem-Loop II Motif: Potential Target for Anti-viral Drugs Medical Countermeasures January 26, 2021 …
Lawmakers Press HSS for Information on Remdesivir Pricing Negotiations with Gilead Medical Countermeasures November 19, 2020 …
